The "Why" Behind Enforcement Is The Key FDA Transparency Issue
This article was originally published in The Tan Sheet
Executive Summary
Enforcement is the most critical area where FDA must be more transparent, said Natural Product Association executive Daniel Fabricant
You may also be interested in...
FDA To Address Industry Questions In Transparency Effort
FDA has expanded its transparency initiative to cover an unanticipated area - explaining how the agency works to the industries it regulates
FDA To Address Industry Questions In Transparency Effort
FDA has expanded its transparency initiative to cover an unanticipated area - explaining how the agency works to the industries it regulates
FDA To Address Industry Questions In Transparency Effort
FDA has expanded its transparency initiative to cover an unanticipated area - explaining how the agency works to the industries it regulates